Vascular Malformations, Skeletal Deformities Including Macrodactyly, Embryonic Veins

Total Page:16

File Type:pdf, Size:1020Kb

Vascular Malformations, Skeletal Deformities Including Macrodactyly, Embryonic Veins 1.) Give a general classification and nomenclature to think about when evaluating these patients 2.) Share some helpful tips to narrow the differential in a minute or less of interaction 3.) Discuss some helpful imaging recommendations focusing on ultrasound Vascular Anomalies Tumors: Malformations: Hemangiomas: Low flow: Infantile Hemangioma (IH) Capillary malformation (CM) Rapidly involuting congenital hemangioma (RICH) Non-involuting congenital hemangioma (NICH) Venous malformation (VM) Kaposiform Hemangioendothelioma Lymphatic malformation (LM) (KHE) High flow: Arteriovenous malformation (AVM) Tufted Angioma (TA) Combined including syndromic VA. Other rare tumors www.issva.org • 2014 ISSVA classification is now 20 pages long • The key is that the imaging characteristics have not changed • Rapidly growing field • Traditionally, options were always the same – Surgery – Do nothing • With the increase in awareness and research as well as the development of the specialty of vascular anomalies: New Treatment Options Available – Treatment directly linked to diagnosis • Today, we have: – Interventional catheter based therapies – Laser surgery – Ablation technologies: Cryo, RFA, Microwave, etc. – Direct image-guided medications to administer – Infusion medicines – Oral medicines – Surgery- although much less common – Do Nothing- a VERY important alternative • Survey sample of 100 Referred patients – 47% wrong Dx – 35% wrong Tx • 14% wrong Tx with correct Dx • VAC – 14% indeterminate or wrong Dx – only 4% leave with no Tx plan • Important because different diagnosis have different treatments! • How to navigate the EMR – Previous surgery or treatment, biopsy report • Family history • Right protocol was done to answer question • Clinical questions • Correct diagnosis • Intralesional clotting • Angioarchitecture • Anatomic space involvement • Hamartomatous component • Single or multifocal, accurate size • Presence of overgrowth • “I have some crazy vascular malformation thing I need you to scan, not sure what I am looking at” • Questions: – How long has it been there, since birth? – Anybody in family have similar? – When did it start hurting or was noticed? – Is it growing fast or with patient? • The glance: – Is there a scar? – Is there skin discoloration? – Is there vesicles? Is there blebs? – Are there hard pebbles? • This is the first fork in the road, very important one • Four helpful differentiators: – Cystic, solid or bundle of vessels – Skin involvement – When did symptoms start – Growth in proportion or out of proportion to patient growth Vascular Anomalies Tumors: Malformations: - Cell proliferation - Normal cell turnover - Can spontaneously involute - No spontaneous involution - Small or absent at birth - Usually seen at birth - Rapid growth during infancy - Growth proportional to patient • Most common vascular tumor • MASS is NOT present at birth, a pink stain in location of future infantile hemangioma can be • Many of these will not be imaged • Proliferation and then involution natural history PHACES LUMBOSACRAL AND MIDLINE NECK/BACK -35-51% of associated deep involvement -Spinal dysraphism, deep involvement -PELVIS, SACRAL, LUMBAR all discuss dysraphism, anogenital, renal, urologic, arterial and bony anomaly syndromes Post Gad • Most clinically significant we see are congenital hemangiomas (RICH and NICH), KHE and Verrucous Hemangioma (unclassified) • Kaposiform Hemangioendothelioma (KHE) clinically significant because of Kasabach-Merritt and Tx. • Congenital Hemangiomas due to bleeding and Tx. • Maximum growth percentage wise at birth • RICH rapidly involutes, see auto infarct signs of cystic/necrotic change and calcification, bleeding • In liver known as Infantile Hemangioendothelioma • Mild Thrombocytopenia (Not like KHE), Cardiomegaly, Heart Failure • NICH grows in proportion to patient, superficial always a bleeding risk, arterial tumor • No medicine works for RICH or NICH, commonly tried • Surgery with or without embolization standard – With RICH, conservative if possible, less is more • Be aware of mimickers: Infantile Fibrosarcoma, KHE infancy 1 year 4 years -observe the veins,Ca++ • KHE locally aggressive vascular neoplasm of children • Kasabach-Merritt phenomenon (KMP) – up to 71% report to have thrombocytopenia • High mortality rate : reported at 24 %, better today • Strong lymphatic component, watch for spread Treatment: – Medical first • mTor inhibitors, namely Sirolimus, now first line, oral • Vincristine has long track record of success also, needs port – Surgery if resection possible – There have been reports of spontaneous involution Behr GG, Johnson CM. Vascular anomalies: hemangiomas and beyond—part 1. Fast-flow lesions. AJR 2013 Feb;200(2):414-22. A B C • Different Type of Lesion, also called Angiokeratoma – Officially “unclassified” in ISSVA, GLUT-1 positive • Must clinically suspect to manage properly • Keratotic, wart-like lesion with red to purple color • Does not involute, with continue growth • Treatment is surgical or CO2 laser • Needs biopsy • No medical therapy successful, many tried • Is it lymphatic malformation? • Is it venous malformation? • Is it arteriovenous malformation? • Cause painful flares, classified macrocystic and microcystic • Fluid/fluid levels of hemorrhage, surrounding inflammation of superinfection, size change • Anatomic location, especially with airway association • Atypical features: calcification, thick walls, nodules • Location, location, location • Outflow size and connection • Clotting, most common with spongiform “grapes” type • Classic misses at VAC: Plexiform N., synovial sarcoma • No mass on imaging despite clinical appearance of mass from edema and eschar • Associated CM suggest autosomal dominant RASA1 • These classically become more symptomatic with puberty and pregnancy, hormonally responsive – Common teenage presentation • The clinical key is steal phenomenon, despite increased flow, decreased oxygenation • Angioarchitecture description key- feeding arteries and draining veins, dominant/codominant • Treatment includes embolization and surgery, no medical therapy proven successful - Four clinical stages: 1. Quiescent 2. Expansion – classic at puberty 3. Destruction (ulceration, bleeding and pain) 4. High outflow heart failure (rare) 16 hours of embo before • Dramatically different management and complications • Should be taken care of by multidisciplinary team when possible • Entities include Klippel Trenaunay (KTS), Parkes Weber (PWS), CLOVES, Proteus and many more • Need to know embryonic anatomy – Lateral Marginal, Sciatic, other – Size, course and outflow communication key • Need to know any macrocystic or focal spongiform VM components and compartments contained • Pay attention to bladder wall, uterus and colonic wall, invasion can be subtle and hugely important • Purely high-flow overgrowth, no masses or slow flow component – Familial seen, CM-AVM, RASA1 mutation • Clinically will look like arterial insufficiency in elderly, AV shunting causes relative distal ischemia • Typically at angio have AVF’s and AVM’s • Complex overgrowth syndrome- Congenital Limb Overgrowth, Vascular Malformation, Epidermal Nevus and Spinal Anomalies/Scoliosis • Significant overlap with KTS- embryonic vein findings most clinically important, can have chest wall and upper extremity • Second and third ray upper/lower macrodactyly The E in cloves • Mosaic, progressive and sporadic – Nature of the syndrome is essential diagnostic criteria – Historically, like KTS, most named Proteus not Proteus • Cerebriform connective tissue nevus is pathognomonic • Hemihypertrophy, kyphoscoliosis, epidermal nevus, vascular malformations, skeletal deformities including macrodactyly, embryonic veins .
Recommended publications
  • Hemangiosarcoma Philip J
    Ettinger & Feldman – Textbook of Veterinary Internal Medicine Client Information Sheet Hemangiosarcoma Philip J. Bergman What is hemangiosarcoma? Hemangiosarcoma (HSA; angiosarcoma or malignant hemangioendothelioma) is an extremely aggressive tumor of blood vessel origin. Because blood vessels are present throughout the body, virtually any site in the body can have HSA. HSA occurs most frequently in dogs (approximately 2% of all tumors) and the most common site is the spleen. However, additional common sites include the heart, liver, muscle, lung skin, bones, kidney, brain, abdomen, and oral cavity. In three large canine splenic disease studies encompassing approximately 2000 dogs, a “rule of two thirds” was found suggesting that approximately two thirds of dogs with a splenic mass have a cancer (therefore one third are not malignant) and two thirds of the malignant tumors of the spleen are HSA. HSA is a disease generally of older dogs and cats with an average onset of 9 to 10 years; however, there are reports of extremely young dogs and cats with this disease (5 to 6 months to a few years of age). German shepherd dogs are most commonly diagnosed with HSA; however, other large breed dogs such as golden retrievers and Labrador retrievers may also be overrepresented. In cats, the most common breed is the domestic shorthair. The cause of HSA in dogs and cats is presently unknown. Exposures to toxins such as chemicals, insecticides, and radiation have been reported in humans to be associated with HSA. Ultraviolet light exposure from the sun may be a potential cause of HSA in dogs, as HSAs of the skin are commonly seen in dogs with light hair and poor pigmentation (e.g., Salukis, Whippets, and white Bulldogs).
    [Show full text]
  • Angiokeratoma of the Scrotum (Fordyce Type) Associated with Angiokeratoma of the Oral Cavity
    208 Letters to the Editor anti-thyroperoxidas e antibody in addition to, or, less Yamada A. Antineutrophil cytoplasmic autoantibody- likely, instead of MPO-ANCA cannot be excluded. positive crescentric glomerulonephritis associated with thi- amazole therapy. Nephron 1996; 74: 734–735. Vesiculo-bullous SLE has been reported to respond 6. Cooper D. Antithyroid drugs. N Engl J Med 1984; 311: to dapsone (15). However, in our patient, an early 1353–1362. aggressive treatment with steroid pulse therapy and 7. Yung RL, Richardson BC. Drug-induced lupus. Rheum plasmapheresis was mandatory because of her life- Dis Clin North Am 1994; 20: 61–86. threatening clinical condition. The contributory factors, 8. Hess E. Drug-related lupus. N Engl J Med 1988; 318: 1460–1462. such as an environmental trigger or an immunological 9. Sato-Matsumura KC, Koizumi H, Matsumura T, factor, for the presence of a serious illness in this patient Takahashi T, Adachi K, Ohkawara A. Lupus eryth- remain to be elucidated. The mechanism by which ematosus-like syndrome induced by thiamazole and methimazole induces SLE-like reactions is unclear. propylthiouracil. J Dermatol 1994; 21: 501–507. 10. Wing SS, Fantus IG. Adverse immunologic eVects of antithyroid drugs. Can Med Assoc J 1987; 136: 121–127. 11. Condon C, Phelan M, Lyons JF. Penicillamine-induced REFERENCES type II bullous systemic lupus erythematosus. Br J Dermatol 1997; 136: 474–475. 1. Alarcon-Segovia D. Drug induced lupus syndromes. Mayo 12. Stankus S, Johnson N. Propylthiouracil-induced hyper- Clin Proc 1969; 44: 664–681.2. sensitivity vasculitis presenting as respiratory failure. Chest 2. Cush JJ, Goldings EA.
    [Show full text]
  • Angiokeratoma of the Scrotum (Fordyce)
    Keio Journal of Medicine Vol. 1, No. 1, January, 1952 ANGIOKERATOMA OF THE SCROTUM (FORDYCE) MASAKATSU IZAKI Department of Dermatology, School of Medicine, Keio University Since Fordyce, in 1896, first described a case of angiokeratoma of the scrotum, many authors have reported and discussed about this dermatosis. However the classification and the nomenclature of this skin disease still remain in a state of confusion. Recently I had a chance to see the report of Robinson and Tasker (1946)(14), discussing the nomenclature of this condition, which held my attention considerably. In this paper I wish to report statistical observation concerning the incidences of this dermatosis among Japanese males, and histopathological studies made in 5 cases of this condition. STATISTICALOBSERVATION It must be first pointed out that this study was made along with the statistical study on angioma senile and same persons were examined in both dermatosis (ref. Studies on Senile Changes in the Skin I. Statistical Observation; Journal of the Keio Medical Society Vol. 28, No. 2, p. 59, 1951). The statistics was handled by the small sampling method. Totals of persons examined were 1552 males. Their ages varied from 16 to 84 years, divided into seven groups: i.e. the late teen-agers (16-20), persons of the third decade (21-30), of the fourth decade (31-40), of the fifth decade (41-50), of the sixth decade (51-60), of the seventh decade (61-70) and a group of persons over 71 years of age. The number of persons and the incidence of this condition in each group are summarized briefly in Table 1.
    [Show full text]
  • Benign Hemangiomas
    TUMORS OF BLOOD VESSELS CHARLES F. GESCHICKTER, M.D. (From tke Surgical Palkological Laboratory, Department of Surgery, Johns Hopkins Hospital and University) AND LOUISA E. KEASBEY, M.D. (Lancaster Gcaeral Hospital, Lancuster, Pennsylvania) Tumors of the blood vessels are perhaps as common as any form of neoplasm occurring in the human body. The greatest number of these lesions are benign angiomas of the body surfaces, small elevated red areas which remain without symptoms throughout life and are not subjected to treatment. Larger tumors of this type which undergb active growth after birth or which are situated about the face or oral cavity, where they constitute cosmetic defects, are more often the object of surgical removal. The majority of the vascular tumors clinically or pathologically studied fall into this latter group. Benign angiomas of similar pathologic nature occur in all of the internal viscera but are most common in the liver, where they are disclosed usually at autopsy. Angiomas of the bone, muscle, and the central nervous system are of less common occurrence, but, because of the symptoms produced, a higher percentage are available for study. Malignant lesions of the blood vessels are far more rare than was formerly supposed. An occasional angioma may metastasize following trauma or after repeated recurrences, but less than 1per cent of benign angiomas subjected to treatment fall into this group. I Primarily ma- lignant tumors of the vascular system-angiosarcomas-are equally rare. The pathological criteria for these growths have never been ade- quately established, and there is no general agreement as to this par- ticular form of tumor.
    [Show full text]
  • Infantile Hemangioendothelioma of the Parotid Gland
    Elmer ress Case Report Int J Clin Pediatr. 2015;4(4):184-185 Infantile Hemangioendothelioma of the Parotid Gland Veeranna A. Kotrashettia, Vijay Baburao Sonawanea, b, Kapil Bainadea, Reshu Agarwala Abstract parotid region, 4 × 3 cm in size, smooth in surface, no pulsa- tions with no signs of inflammation (Fig. 1). Tumors of salivary glands are uncommon in children (less than 5%). Complete blood count was normal. USG revealed en- Hemangioma is the commonest tumor of salivary gland tumors (more larged parotid gland measuring 3.1 × 2.2 × 2.5 cm with in- than 50%). We report a rare case of infantile hemangioma (IH) of creased vascularity. parotid gland. MRI showed well-defined, lobulated homogenously en- hancing leison diffusely involving the superficial and deep Keywords: Hemangioma; Hemangioendothelioma; Parotid gland layers of parotid gland (Fig. 2). Findings are suggestive of in- fantile hemangioendothelioma. Introduction Discussion Infantile hemangiomas (IHs) are the most common tumor of IH of parotid gland is the most common tumor. Weiss and oth- infancy and have a well-described natural history of rapid growth during early infancy followed by gradual involution [1, 2]. Congenital capillary hemangioma is classified as true hemangioma of infancy [3]. It is usually not noticed in new- born period but becomes prominent in first months of life. Most common age of presentation is about 4 months. Parotid hemangioma demonstrates rapid growth in first months of life but usually regresses after 18 months [4]. MRI is the best im- aging technique to demonstrate parotid hemangioma. MRI shows hyperintense parotid gland hemangioma con- taining vascular flow voids.
    [Show full text]
  • Angiosarcomas and Other Sarcomas of Endothelial Origin
    Angiosarcomas and Other Sarcomas of Endothelial Origin a,b a Angela Cioffi, MD , Sonia Reichert, MD , c a,b,d, Cristina R. Antonescu, MD , Robert G. Maki, MD, PhD, FACP * KEYWORDS Angiosarcoma Epithelioid hemangioendothelioma Vascular sarcoma Kaposi sarcoma VEGF KDR FLT4 Translocation Organ transplant KEY POINTS Vascular sarcomas are rare and collectively affect fewer than 600 people a year in the United States (incidence approximately 2/million). Because angiosarcomas, hemangioendotheliomas, and other vascular tumors have unique embryonal derivation, it is not surprising that they have a unique sensitivity pattern to chemotherapy agents. Surgery, when possible, remains the primary treatment for angiosarcomas. Adjuvant radiation for primary disease seems prudent for at least some angiosarcoma, given the high local-regional recurrence rate of these tumors. Angiosarcomas also have a high rate of metastasis, but it is not clear that adjuvant chemotherapy improves survival. Epithelioid hemangioendothelioma is a unique form of sarcoma often presenting as multi- focal disease. Most patients can do well with observation alone, although a fraction of pa- tients have more aggressive disease and have difficulties in both local control and metastatic disease. Continued Disclosures: R.G. Maki receives clinical research support from Morphotek/Eisai, Ziopharm, and Imclone/Lilly. He has also consulted for Eisai, Morphotek/Eisai, Imclone/Lilly, Taiho, Glaxo- SmithKline, Merck, Champions Biotechnology, and Pfizer. He has received speaker’s fees from Novartis. He is an unpaid consultant for the Sarcoma Foundation of America, SARC: Sarcoma Alliance for Research through Collaboration, n-of-one, and 23 & me. C.R. Antonescu, A. Cioffi, and S. Reichert report no conflicts.
    [Show full text]
  • View Open Access Histological Variants of Cutaneous Kaposi Sarcoma Wayne Grayson1 and Liron Pantanowitz*2
    Diagnostic Pathology BioMed Central Review Open Access Histological variants of cutaneous Kaposi sarcoma Wayne Grayson1 and Liron Pantanowitz*2 Address: 1Histopathology Department, Ampath National Laboratory Support Services, Johannesburg, South Africa and 2Department of Pathology, Baystate Medical Center, Tufts University School of Medicine, Springfield, Massachusetts, USA Email: Wayne Grayson - [email protected]; Liron Pantanowitz* - [email protected] * Corresponding author Published: 25 July 2008 Received: 23 July 2008 Accepted: 25 July 2008 Diagnostic Pathology 2008, 3:31 doi:10.1186/1746-1596-3-31 This article is available from: http://www.diagnosticpathology.org/content/3/1/31 © 2008 Grayson and Pantanowitz; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract This review provides a comprehensive overview of the broad clinicopathologic spectrum of cutaneous Kaposi sarcoma (KS) lesions. Variants discussed include: usual KS lesions associated with disease progression (i.e. patch, plaque and nodular stage); morphologic subtypes alluded to in the older literature such as anaplastic and telangiectatic KS, as well as several lymphedematous variants; and numerous recently described variants including hyperkeratotic, keloidal, micronodular, pyogenic granuloma-like, ecchymotic, and intravascular KS. Involuting lesions as a result of treatment related regression are also presented. Introduction progression, (2) KS variants alluded to in the older litera- Kaposi sarcoma (KS) is a vascular lesion of low-grade ture, (3) more recently described KS variants, and (4) KS malignant potential that presents most frequently with lesions as a consequence of therapy.
    [Show full text]
  • Mesenchymal) Tissues E
    Bull. Org. mond. San 11974,) 50, 101-110 Bull. Wid Hith Org.j VIII. Tumours of the soft (mesenchymal) tissues E. WEISS 1 This is a classification oftumours offibrous tissue, fat, muscle, blood and lymph vessels, and mast cells, irrespective of the region of the body in which they arise. Tumours offibrous tissue are divided into fibroma, fibrosarcoma (including " canine haemangiopericytoma "), other sarcomas, equine sarcoid, and various tumour-like lesions. The histological appearance of the tamours is described and illustrated with photographs. For the purpose of this classification " soft tis- autonomic nervous system, the paraganglionic struc- sues" are defined as including all nonepithelial tures, and the mesothelial and synovial tissues. extraskeletal tissues of the body with the exception of This classification was developed together with the haematopoietic and lymphoid tissues, the glia, that of the skin (Part VII, page 79), and in describing the neuroectodermal tissues of the peripheral and some of the tumours reference is made to the skin. HISTOLOGICAL CLASSIFICATION AND NOMENCLATURE OF TUMOURS OF THE SOFT (MESENCHYMAL) TISSUES I. TUMOURS OF FIBROUS TISSUE C. RHABDOMYOMA A. FIBROMA D. RHABDOMYOSARCOMA 1. Fibroma durum IV. TUMOURS OF BLOOD AND 2. Fibroma molle LYMPH VESSELS 3. Myxoma (myxofibroma) A. CAVERNOUS HAEMANGIOMA B. FIBROSARCOMA B. MALIGNANT HAEMANGIOENDOTHELIOMA (ANGIO- 1. Fibrosarcoma SARCOMA) 2. " Canine haemangiopericytoma" C. GLOMUS TUMOUR C. OTHER SARCOMAS D. LYMPHANGIOMA D. EQUINE SARCOID E. LYMPHANGIOSARCOMA (MALIGNANT LYMPH- E. TUMOUR-LIKE LESIONS ANGIOMA) 1. Cutaneous fibrous polyp F. TUMOUR-LIKE LESIONS 2. Keloid and hyperplastic scar V. MESENCHYMAL TUMOURS OF 3. Calcinosis circumscripta PERIPHERAL NERVES II. TUMOURS OF FAT TISSUE VI.
    [Show full text]
  • A Case of Lymphangioleiomyomatosis Originated in the Pelvic Cavity
    J Gynecol Oncol Vol. 19, No. 3:195-198, September 2008 DOI:10.3802/jgo.2008.19.3.195 Case Report A case of lymphangioleiomyomatosis originated in the pelvic cavity Jung-Mi Han, Kyung-Hee Lee, Sung-Joo Kim, Chae-Chun Rhim, Young-Han Park, Jung-Bae Kang, Sun-Young Jeon1 Departments of Obstetrics and Gynecology, 1Pathology, Hallym University Medical College, Anyang, Korea Lymphangioleiomyomatosis is a rare disease that is characterized by proliferation of abnormal smooth muscle-like cells, especially that which occurs in the pulmonary parenchyme. It primarily affects women of child-bearing age. The majority of primary lymphangioleiomyomatosis occurs in the lung, but there are a few reports of extrapulmonary cases. We experienced a rare case of lymphangioleiomyomatosis which originated in the pelvic cavity (in the posterior portion of the uterus), and report with brief review of literatures. Key Words: Lymphangioleiomyomatosis, Pelvis, Uterus INTRODUCTION hypervascular tumor between the uterus and the right ovary, and two small myomas about 2 cm in size (Fig. 1). Under the Lymphangioleiomyomatosis is a very rare disease which impression of ovarian malignancy she had admitted for shows typical features of abnormal smooth muscle cell further evaluation including MRI. Her initial serum CA-125 proliferation and which develops in females during the level was 26.7 U/ml and CA 19-9 level was below 2 U/ml, and reproductive period.1,2 The majority cases of this disease other hematologic findings were all within the normal range. primarily occur in the lungs, but extrapulmonary regions such Magnetic resonance imaging study of the abdomen-pelvis as the pelvis and retroperitoneal spaces are occasionally demonstrated an approximately 4.0×5.0×4.0 cm sized tumor primary sites.
    [Show full text]
  • Early Lesions of Kaposi's Sarcoma in Homosexual Men an Ultrastructural Comparison with Other Vascular Proliferations in Skin
    Early Lesions of Kaposi's Sarcoma in Homosexual Men An Ultrastructural Comparison With Other Vascular Proliferations in Skin N. SCOTT McNUTT, MD, VAN FLETCHER, MD and From the Departments of Pathology and Dermatology and the Kaposi MARCUS A. CONANT, MD Sarcoma Study Group, Veterans Administration Medical Center, and the University of California, San Francisco, California An aggressive variant of Kaposi's sarcoma (KS) has ap- thelial lining, and had only a few small junctional peared in young homosexual men with evidence of sys- densities between endothelial cells. Some clinically temic immunosuppression. The ultrastructure in biop- aggressive cases of KS also had necrosis of individual sy specimens from 8 KS cases in young homosexual endothelial cells and had prominent cytoplasmic pro- men has been compared with that in biopsy specimens cesses entrapping individual collagen fibers. The be- from 4 KS cases in elderly heterosexuals and with that nign disorders lacked these features. These differences in biopsy specimens from 23 cases of benign vascular in the structure of the small vessels may be of diagnos- disorders of skin. In all cases of KS the small blood ves- tic value in some early cases ofKS. The loss ofdendritic sels lacked a prominent investment of pericytes and pericytes in blood capillaries in KS might relate to the their processes, had a fragmented and often absent telangiectasia which is a prominent feature of the early basal lamina, had frequent discontinuities in the endo- lesions of KS. (Am J Pathol 1983, 111:62-77) A DRAMATIC CHANGE in the epidemiology and patients the disease progresses rapidly, and they die clinical course of the vascular neoplasm called of KS within 1 year, despite standard combination Kaposi's sarcoma (KS) has occurred in the United drug chemotherapy regimens.4 States since 1981.
    [Show full text]
  • Kaposiform Hemangioendothelioma in Tonsil of a Child
    Rekhi et al. World Journal of Surgical Oncology 2011, 9:57 http://www.wjso.com/content/9/1/57 WORLD JOURNAL OF SURGICAL ONCOLOGY CASEREPORT Open Access Kaposiform hemangioendothelioma in tonsil of a child associated with cervical lymphangioma: a rare case report Bharat Rekhi1*, Shweta Sethi1, Suyash S Kulkarni2 and Nirmala A Jambhekar1 Abstract Kaposiform hemangioendothelioma (KHE) is an uncommon vascular tumor of intermediate malignant potential, usually occurs in the extremities and retroperitoneum of infants and is characterized by its association with lymphangiomatosis and Kasabach-Merritt phenomenenon (KMP) in certain cases. It has rarely been observed in the head and neck region and at times, can present without KMP. Herein, we present an extremely uncommon case of KHE occurring in tonsil of a child, associated with a neck swelling, but unassociated with KMP. A 2-year-old male child referred to us with history of sore throat, dyspnoea and right-sided neck swelling off and on, since birth, was clinicoradiologically diagnosed with recurrent tonsillitis, including right sided peritonsillar abscess, for which he underwent right-sided tonsillectomy, elsewhere. Histopathological sections from the excised tonsillar mass were reviewed and showed a tumor composed of irregular, infiltrating lobules of spindle cells arranged in kaposiform architecture with slit-like, crescentic vessels. The cells displayed focal lumen formation containing red blood cells (RBCs), along with platelet thrombi and eosinophilic hyaline bodies. In addition, there were discrete foci of several dilated lymphatic vessels containing lymph and lymphocytes. On immunohistochemistry (IHC), spindle cells were diffusely positive for CD34, focally for CD31 and smooth muscle actin (SMA), the latter marker was mostly expressed around the blood vessels.
    [Show full text]
  • Angiokeratoma.Pdf
    Classification of vascular tumors/nevi Vascular tumors mainly of infancy and childhood • Hemangioma of infancy. • Congenital hemangioma. • Miliary hemangiomatosis of infancy. • Spindle cell hemangioma. • Kaposiform hemangioendothelioma. • Tufted angioma. • Sinusoidal hemagioma. Vascular malformation - Capillary: • Salmon patch. • Potr-wine stain. • Nevus anemicus. - Mixed vascular malformation: • Reticulate vascular nevus. • Klipple ternaunay syndrome. • Venous malformation. • Blue rubber bleb nevus syndrome. • Maffucci syndrome. • Zosteriform venous malformation. • Other multiple vascular malformation syndrome. - Lymphatic malformations: • Microcystic/Macrocystic. • Rapid flow (arteriovenous malformation). Angiokeratoma: • Angiokeratoma circumscriptum naeviforme. • Angiokeratoma of Mibelli (or angiokeratoma acroasphyticum digitorum) . • Solitary papular angiokeratoma. • Angiokeratoma of fordyce (or angiokeratoma scroti). • Angiokeratoma corporis diffusum. Cutanous vascular hyperplasia: • Lobular capillary hemangioma. • Epithelioid hemangioma. • Crisoid aneurysm. • Reactive angioendotheliomatosis. • Gromeruloid hemangioma. • Hobnail hemangioma. • Microvascular hemangioma. Benign neoplasm: • Glomus tumors. Malignancy: • Kaposi sarcoma. • Angiosarcoma. • Retiform hemangioendothelioma. Modified classification of the International Society for the Study of Vascular Anomalies (Rome, Italy, 1996) : Tumors: -Hemangiomas: • Superficial (capillary or strawberry haemangioma). • Deep (cavernous haemangioma). • Combined. - Others: • Kaposiform
    [Show full text]